What is Jon W. Salveson’s Artivion (AORT) share ownership after this Form 4 transaction?

Following the grant, Salveson directly holds 137,416 shares of Artivion common stock. This total includes the newly awarded 7,576 shares, which are subject to vesting conditions specified in the company’s Equity and Cash Incentive Plan and vesting schedule.

Artivion director receives 7,576-share stock grant

Salveson Jon W reported acquisition or exercise transactions in this Form 4 filing.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Salveson Jon W reported acquisition or exercise transactions in this Form 4 filing.

ARTIVION, INC. director Jon W. Salveson reported receiving a grant of 7,576 shares of common stock as a stock award. The shares were granted at no cash cost to him and are scheduled to vest on May 18, 2027 under the company’s Equity and Cash Incentive Plan. After this award, his direct holdings increased to 137,416 shares of Artivion common stock.

Insider Trade Summary

Grant/Award: 7,576 shares

Grant/Award 1 txn

Insider Salveson Jon W

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,576	$0.00	$0.00

Holdings After Transaction: Common Stock — 137,416 shares (Direct)

Footnotes (1)

F1. RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

Key Figures

Shares granted: 7,576 shares Post-transaction holdings: 137,416 shares Transaction code: Code A +2 more

5 metrics

Shares granted 7,576 shares Restricted stock award on May 18, 2026

Post-transaction holdings 137,416 shares Total Artivion common shares directly held after grant

Transaction code Code A Grant, award, or other acquisition of common stock

Reported transaction price $0.00 per share Indicates compensation award, not open-market purchase

Vesting date May 18, 2027 RSA grant vests under Equity and Cash Incentive Plan

Key Terms

RSA Grant, Equity and Cash Incentive Plan, Grant, award, or other acquisition, Common Stock

4 terms

RSA Grant financial

"RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan."

Equity and Cash Incentive Plan financial

"RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan."

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Jon W. Salveson report for Artivion (AORT)?

Jon W. Salveson reported receiving a grant of 7,576 Artivion common shares. The award was recorded as an acquisition at no cash cost and is part of his director compensation, increasing his direct holdings to a total of 137,416 common shares after the transaction.

How many Artivion (AORT) shares were granted to Jon W. Salveson and at what price?

He was granted 7,576 shares of Artivion common stock at a reported price of $0.00 per share. This reflects a compensation-related stock award rather than an open-market purchase, consistent with the Form 4 code "A" for grant or award acquisition.

When do Jon W. Salveson’s new Artivion (AORT) shares vest?

The Form 4 footnote states the RSA grant vests on May 18, 2027. Vesting occurs pursuant to the terms of Artivion’s Equity and Cash Incentive Plan, meaning Salveson fully earns the awarded shares on that specific future vesting date.

Is Jon W. Salveson’s Artivion (AORT) Form 4 transaction a market buy or sell?

No, the transaction is not a market buy or sell. It is coded "A" on Form 4, indicating a grant or award acquisition. The reported price is $0.00 per share, signifying compensation through restricted stock rather than an open-market trade.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/20/2026 - 08:35 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Salveson Jon W

(Last)

(First)

(Middle)

ARTIVION INC

1655 ROBERTS BLVD NW

(Street)

KENNESAW

GEORGIA

30144

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/18/2026		A		7,576⁽¹⁾	A	$0	137,416	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

Remarks:

	/s/ Jon W. Salveson	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR